PuSH - Publikationsserver des Helmholtz Zentrums München

75 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Thomas, J. et al.: CD23 levels on B cells determine long-term therapeutic response in patients with atopic eczema treated with selective IgE immune apheresis. J. Invest. Dermatol. 141, 681-685.e6 (2021)
2.
Chuah, S.Y.* et al.: Volumetric multispectral optoacoustic tomography for 3-dimensional reconstruction of skin tumors: A further evaluation with histopathologic correlation. J. Invest. Dermatol. 139, 481-485 (2019)
3.
Eyerich, K.* & Eyerich, S.: Immune response patterns in chronic inflammatory skin diseases a basis of targeted therapy. J. Invest. Dermatol. 138, S16-S16 (2018)
4.
Heppt, M.V.* et al.: MSX1-induced neural crest-like reprogramming promotes melanoma progression. J. Invest. Dermatol. 138, 141-149 (2018)
5.
Hiller, J. et al.: STAT1 gain-of-function and dominant negative STAT3 mutations impair IL-17 and IL-22 immunity associated with CMC. J. Invest. Dermatol. 138, 711-714 (2018)
6.
Jargosch, M.* et al.: Necroptosis as special type of cell death in inflammatory skin diseases. J. Invest. Dermatol. 138, S116-S116 (2018)
7.
Lauffer, F.* et al.: Type I immune response induces keratinocyte necroptosis and is associated with interface dermatitis. J. Invest. Dermatol., DOI: 10.1016/j.jid.2018.02.034 (2018)
8.
Schmidt, M.O.* et al.: The role of Fibroblast growth factor binding protein 1 in skin carcinogenesis and inflammation. J. Invest. Dermatol. 138, 179-188 (2018)
9.
Buters, J.T.M. & Biedermann, T.*: Chromium(VI) contact dermatitis: Getting closer to understanding the underlying mechanisms of toxicity and sensitization! J. Invest. Dermatol. 137, 274-277 (2017)
10.
Fuertes, E.* ; Flohr, C.* ; Silverberg, J.I.* ; Standl, M. & Strachan, D.P.*: Global associations between UVR exposure and current eczema prevalence in children from ISAAC Phase Three. J. Invest. Dermatol. 137, 1248-1256 (2017)
11.
Garzorz-Stark, N.* et al.: TLR7/8 agonists stimulate plasmacytoid dendritic cells to initiate a Th17-deviated acute contact dermatitis in humans. J. Invest. Dermatol. 137, S275-S275 (2017)
12.
Guttman-Yassky, E.* et al.: A pathogenic role for Th22/IL-22 in atopic dermatitis is established by a placebo-controlled trial with an anti IL-22/ILV-094 mAb. J. Invest. Dermatol. 137, S53-S53 (2017)
13.
Hermann, H.* et al.: miR-146b probably assists miRNA-146a in the suppression of keratinocyte proliferation and inflammatory responses in psoriasis. J. Invest. Dermatol. 137, 1945-1954 (2017)
14.
Kong, H.H.* et al.: Performing skin microbiome research: A method to the madness. J. Invest. Dermatol. 137, 561-568 (2017)
15.
Laemmermann, I.* et al.: Blocking negative effects of senescence in human skin fibroblasts with a plant extract. J. Invest. Dermatol. 137, S311-S311 (2017)
16.
Lauffer, F.* et al.: Interface Dermatitis is characterized by a type I immune response and an epidermal reaction to IFN-gamma and TNF-alpha. J. Invest. Dermatol. 137, S254-S254 (2017)
17.
Standl, M. et al.: Association of atopic dermatitis with cardiovascular risk factors and diseases. J. Invest. Dermatol. 137, 1074-1081 (2017)
18.
Terlecki-Zaniewicz, L.* et al.: Senescent human fibroblasts selectively secrete miRNAs in extracellular vesicles and modulate keratinocyte functionality during skin aging. J. Invest. Dermatol. 137, S250-S250 (2017)
19.
Aguirre Bueno, J. et al.: Assessment of psoriasis using label-free ultra-broadband optoacoustic mesoscopy. J. Invest. Dermatol. 136, S217-S217 (2016)
20.
Altunbulakli, C.* et al.: Transcriptomic analysis of epidermal barrier molecules, cytokines and growth factors in atopic dermatitis lesions. J. Invest. Dermatol. 136, S177-S177 (2016)